duloxetine hydrochloride has been researched along with Coronary Artery Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Baker, RA; Bennetts, JS; Cardinal, T; Tully, PJ | 1 |
2 other study(ies) available for duloxetine hydrochloride and Coronary Artery Disease
| Article | Year |
|---|---|
The prevalence of duloxetine in medico-legal death investigations in Victoria, Australia (2009-2012).
Topics: Adult; Aged; Antidepressive Agents; Australia; Cardiomegaly; Cause of Death; Chromatography, Liquid; Cohort Studies; Coronary Artery Disease; Coroners and Medical Examiners; Drug Interactions; Duloxetine Hydrochloride; Female; Forensic Toxicology; Humans; Male; Middle Aged; Pharmaceutical Preparations; Prevalence; Pulmonary Edema; Tandem Mass Spectrometry; Thiophenes | 2014 |
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
Topics: Aged; Aged, 80 and over; Australia; Coronary Artery Bypass; Coronary Artery Disease; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Hospital Mortality; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Hemorrhage; Proportional Hazards Models; Renal Dialysis; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2012 |